ANAB 22.4 (+5.11%)
US0327241065BiotechnologyBiotechnology

AnaptysBio (ANAB) Financial Metrics

This table shows a selected set of financial data points of AnaptysBio (ANAB). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -6.08 0 -3.52 576.71M -0.31 17.16M -121.61M -135.83M -163.62M 35.97M
2022 -4.57 0 -6.78 872.83M -0.21 10.29M -73.95M -105.26M -128.72M 71.31M
2021 -2.11 0 -16.49 953.23M -0.11 63.18M -47.29M -54.26M -57.8M 495.73M
2020 -0.73 0 -29.45 586.99M -0.05 75M -14.73M -18.31M -19.93M 250.46M
2019 -3.6 0 -4.52 439.71M -0.21 8M -70.32M -96.45M -97.34M 171.02M
2018 -2.5 0 -25.53 1.57B -0.15 5M -49.57M -59.88M -61.66M 113.6M
2017 -1.52 0 -66.26 1.99B -0.15 10M -19.73M -28.11M -30.07M 81.19M
2016 -0.23 0 0 0 -0.07 16.68M -9.08M -3.57M -4.26M 51.23M
2015 -0.49 0 0 0 -0.13 17.57M -9.91M -4.53M -5.41M 51.68M
2014 0.06 0 0 0 0.24 15.84M 14.46M 5.12M 3.53M 22.19M
2013 -0.09 0 0 0 0 5.48M -5.83M -4.08M -5.55M 2.81M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.